We invest in companies which:
- Develop drugs to address large unmet clinical needs
- Develop a proprietary technology platform addressing a rapidly growing market
- Recruit an experienced management team with proven industry expertise.
- Provide a substantial return on invested capital
We would provide our portfolio companies with value added services, develop market access, launch new product and recruit key management in both US and China.
We invest as early as the seed stage and as late as post-IPO rounds. ETP is comfortable acting as a lead investor or partner in syndicated rounds where the key elements for success are already in place.